MetLife Investment Management’s Mersana Therapeutics MRSN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-2,926
| Closed | -$105K | – | 2809 |
|
|
2024
Q4 | $105K | Buy |
2,926
+1,569
| +116% | +$56.1K | ﹤0.01% | 2602 |
|
|
2024
Q3 | $64.1K | Sell |
1,357
-1,266
| -48% | -$59.8K | ﹤0.01% | 2728 |
|
|
2024
Q2 | $132K | Buy |
2,623
+627
| +31% | +$31.5K | ﹤0.01% | 2469 |
|
|
2024
Q1 | $224K | Buy |
1,996
+130
| +7% | +$14.6K | ﹤0.01% | 2140 |
|
|
2023
Q4 | $108K | Hold |
1,866
| – | – | ﹤0.01% | 2573 |
|
|
2023
Q3 | $59.2K | Hold |
1,866
| – | – | ﹤0.01% | 2804 |
|
|
2023
Q2 | $153K | Hold |
1,866
| – | – | ﹤0.01% | 2425 |
|
|
2023
Q1 | $192K | Hold |
1,866
| – | – | ﹤0.01% | 2250 |
|
|
2022
Q4 | $273K | Hold |
1,866
| – | – | ﹤0.01% | 2048 |
|
|
2022
Q3 | $315K | Buy |
1,866
+326
| +21% | +$55.1K | ﹤0.01% | 1982 |
|
|
2022
Q2 | $178K | Buy |
1,540
+541
| +54% | +$62.5K | ﹤0.01% | 2401 |
|
|
2022
Q1 | $99.6K | Sell |
999
-82
| -8% | -$8.18K | ﹤0.01% | 2626 |
|
|
2021
Q4 | $168K | Buy |
1,081
+386
| +56% | +$60K | ﹤0.01% | 2166 |
|
|
2021
Q3 | $164K | Sell |
695
-338
| -33% | -$79.7K | ﹤0.01% | 2206 |
|
|
2021
Q2 | $351K | Buy |
1,033
+187
| +22% | +$63.5K | ﹤0.01% | 1790 |
|
|
2021
Q1 | $342K | Sell |
846
-71
| -8% | -$28.7K | ﹤0.01% | 1741 |
|
|
2020
Q4 | $610K | Hold |
917
| – | – | 0.01% | 1380 |
|
|
2020
Q3 | $427K | Buy |
917
+86
| +10% | +$40K | ﹤0.01% | 1450 |
|
|
2020
Q2 | $486K | Buy |
831
+97
| +13% | +$56.8K | 0.01% | 1396 |
|
|
2020
Q1 | $107K | Buy |
+734
| New | +$107K | ﹤0.01% | 2035 |
|